Measles vaccine vectors and methods of use

ECU Author/Contributor (non-ECU co-authors, if there are any, appear on document)
Harriet Robinson (Creator)
Ted Ross (Creator)
East Carolina University (ECU )
Web Site:

Abstract: The present invention provides a novel vaccine expressing a fusion of the measles hemagglutinin (H) protein and the complement component , C3d , to enhance the titers of neutralizing antibody. Plasmids were generated that expressed a secreted (s) form of H and the same form fused to three tandem copies of the murine homologue of C3d (sH-3C3d). Analysis of titers of the antibody raised in vaccinated mice indicated that groups vaccinated with the DNA construct expressing sH-3C3d had higher titers of anti-H antibodies compared to serum from mice vaccinated with DNA expressing sH only. In addition , sH-3C3d elicited higher neutralizing antibody titers that inhibited MV induced plaque formation.

Additional Information

Language: English
Date: 2003
immunization, Vaccine

Email this document to

This item references:

TitleLocation & LinkType of Relationship
Measles vaccine vectors and methods of use described resource references, cites, or otherwise points to the related resource.